AZ deepens ties with Myriad on Lynparza companion test

4th January 2018 Uncategorised 0

AstraZeneca has expanded its agreement with US group Myriad Genetics to identify women with advanced ovarian cancer most likely to benefit from its medicines.

More: AZ deepens ties with Myriad on Lynparza companion test
Source: News